These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17917510)

  • 41. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.
    Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortolotto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Afiune Neto A; Scala LC; Mota M; Chaves H; Alves JG; Sobral Filho DC; Pereira e Silva R; Figueiredo Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
    Trials; 2011 Feb; 12():53. PubMed ID: 21349192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A; Meloni G
    Minerva Med; 1967 Nov; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract]   [Full Text] [Related]  

  • 43. Validation of a therapeutic scheme for the treatment of resistant hypertension.
    Segura J; Cerezo C; Garcia-Donaire JA; Schmieder RE; Praga M; de la Sierra A; Ruilope LM
    J Am Soc Hypertens; 2011; 5(6):498-504. PubMed ID: 21963042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus.
    Weidmann P; Beretta-Piccoli C; Keusch G; Glück Z; Mujagic M; Grimm M; Meier A; Ziegler WH
    Am J Med; 1979 Nov; 67(5):779-84. PubMed ID: 507089
    [No Abstract]   [Full Text] [Related]  

  • 46. Metoprolol with and without chlorthalidone in hypertension.
    Kubik M; Kendall M; Ebbutt A; John V
    Clin Pharmacol Ther; 1979 Jan; 25(1):25-32. PubMed ID: 363333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modifying elevated blood pressure: a practical office approach.
    Tobian L
    Minn Med; 1969 Aug; 52(8):1307-10. PubMed ID: 5805001
    [No Abstract]   [Full Text] [Related]  

  • 48. [Relation between the hypotensive and renin-stimulating effect of diuretic therapy in hypertensive patients].
    Bianchini C; Sala C; Terzoli L; Sernesi L; Leonetti G; Zanchetti A
    Boll Soc Ital Cardiol; 1978; 23(10):1739-47. PubMed ID: 400389
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
    George CF; Breckenridge AM; Dollery CT
    Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of chlorthalidone and spironolactone as additional diuretic therapy in patients with acute heart failure and preserved ejection fraction.
    Llàcer P; Núñez J; García M; Ruiz R; López G; Fabregate M; Fernández C; Croset F; Del Hoyo B; Gomis A; Manzano L
    Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(4):350-355. PubMed ID: 35167653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
    Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
    Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project?
    Volpe M; Liuzzo G
    Eur Heart J; 2023 Apr; 44(13):1110-1111. PubMed ID: 36786664
    [No Abstract]   [Full Text] [Related]  

  • 53. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
    J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.
    Pareek AK; Messerli FH; Chandurkar NB; Dharmadhikari SK; Godbole AV; Kshirsagar PP; Agarwal MA; Sharma KH; Mathur SL; Kumbla MM
    J Am Coll Cardiol; 2016 Feb; 67(4):379-389. PubMed ID: 26821625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diuretics for hypertension: Hydrochlorothiazide or chlorthalidone?
    Cooney D; Milfred-LaForest S; Rahman M
    Cleve Clin J Med; 2015 Aug; 82(8):527-33. PubMed ID: 26270432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responses of catecholamines and blood pressure to beta-blockade in diuretic-treated patients with essential hypertension.
    Meier A; Weidmann P; Ziegler WH
    Klin Wochenschr; 1982 Jan; 60(1):27-32. PubMed ID: 6122752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension.
    Louis WJ; Doyle AE; Dawborn JK; Johnston CI
    Med J Aust; 1973 Jul; 2(1):23-5. PubMed ID: 4725465
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Choice of diuretic therapy and reconsideration for aldosterone receptors blockers.
    Armanini D; Fiore C
    Hypertension; 2010 Jan; 55(1):e5. PubMed ID: 19948981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.